SKAN Group AG

SKAN Group AG’s AGM confirmed a CHF 0.22 dividend, board continuity with new regulator‑expert Dr. Schlögel, and solid growth prospects in aseptic biopharma tech.

SKAN Group AG, a leading healthcare supplier in Switzerland, has announced that Jonas Greutert will succeed Thomas Huber as CEO, effective January 1, 2026, marking a strategic leadership transition.